Connor, Clark & Lunn Investment Management (CC&L)’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-701,197
Closed -$35M 1589
2025
Q2
$35M Sell
701,197
-515,302
-42% -$23.3M 0.12% 151
2025
Q1
$35.9M Buy
1,216,499
+43,525
+4% +$1.62M 0.16% 112
2024
Q4
$28.4M Sell
1,172,974
-523,901
-31% -$13M 0.13% 126
2024
Q3
$31.3M Sell
1,696,875
-646,704
-28% -$11.6M 0.15% 110
2024
Q2
$47.3M Buy
2,343,579
+916,321
+64% +$15.2M 0.2% 103
2024
Q1
$22.1M Buy
1,427,258
+616,326
+76% +$6.95M 0.1% 189
2023
Q4
$7.22M Buy
810,932
+237,091
+41% +$1.75M 0.03% 338
2023
Q3
$3.61M Sell
573,841
-10,367
-2% -$77.1K 0.02% 477
2023
Q2
$5.49M Sell
584,208
-91,198
-14% -$904K 0.03% 378
2023
Q1
$6.7M Buy
675,406
+334,081
+98% +$2.93M 0.04% 316
2022
Q4
$2.19M Buy
341,325
+231,004
+209% +$1.32M 0.01% 519
2022
Q3
$616K Buy
+110,321
New +$665K ﹤0.01% 773

Other funds holding HIMS

Connor, Clark & Lunn Investment Management (CC&L)'s HIMS Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 701,197 shares — an estimated $35M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HIMS in Q3 2022 and held it in 12 quarters. The position peaked at $47.3M in Q2 2024. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 701,197 Hims & Hers Health shares in Q3 2025, an estimated $35M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Hims & Hers Health in Q3 2022 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Hims & Hers Health position peaked at $47.3M in Q2 2024.
  • 512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.